Publikation:

Comparing in vitro human liver models to in vivo human liver using RNA-Seq

Lade...
Vorschaubild

Dateien

Gupta_2-1efbx95aptpk2.pdf
Gupta_2-1efbx95aptpk2.pdfGröße: 6.73 MBDownloads: 143

Datum

2021

Autor:innen

Gupta, Rajinder
Schrooders, Yannick
Hauser, Duncan
van Herwijnen, Marcel
Albrecht, Wiebke
Ter Braak, Bas
Brecklinghaus, Tim
Castell, Jose V.
Caiment, Florian
et al.

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

ArXiv-ID

Internationale Patentnummer

Link zur Lizenz

Angaben zur Forschungsförderung

European Union (EU): 681002

Projekt

EUToxRisk21
Open Access-Veröffentlichung
Open Access Hybrid
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

Archives of Toxicology. Springer. 2021, 95(2), pp. 573-589. ISSN 0340-5761. eISSN 1432-0738. Available under: doi: 10.1007/s00204-020-02937-6

Zusammenfassung

The liver plays an important role in xenobiotic metabolism and represents a primary target for toxic substances. Many different in vitro cell models have been developed in the past decades. In this study, we used RNA-sequencing (RNA-Seq) to analyze the following human in vitro liver cell models in comparison to human liver tissue: cancer-derived cell lines (HepG2, HepaRG 3D), induced pluripotent stem cell-derived hepatocyte-like cells (iPSC-HLCs), cancerous human liver-derived assays (hPCLiS, human precision cut liver slices), non-cancerous human liver-derived assays (PHH, primary human hepatocytes) and 3D liver microtissues. First, using CellNet, we analyzed whether these liver in vitro cell models were indeed classified as liver, based on their baseline expression profile and gene regulatory networks (GRN). More comprehensive analyses using non-differentially expressed genes (non-DEGs) and differential transcript usage (DTU) were applied to assess the coverage for important liver pathways. Through different analyses, we noticed that 3D liver microtissues exhibited a high similarity with in vivo liver, in terms of CellNet (C/T score: 0.98), non-DEGs (10,363) and pathway coverage (highest for 19 out of 20 liver specific pathways shown) at the beginning of the incubation period (0 h) followed by a decrease during long-term incubation for 168 and 336 h. PHH also showed a high degree of similarity with human liver tissue and allowed stable conditions for a short-term cultivation period of 24 h. Using the same metrics, HepG2 cells illustrated the lowest similarity (C/T: 0.51, non-DEGs: 5623, and pathways coverage: least for 7 out of 20) with human liver tissue. The HepG2 are widely used in hepatotoxicity studies, however, due to their lower similarity, they should be used with caution. HepaRG models, iPSC-HLCs, and hPCLiS ranged clearly behind microtissues and PHH but showed higher similarity to human liver tissue than HepG2 cells. In conclusion, this study offers a resource of RNA-Seq data of several biological replicates of human liver cell models in vitro compared to human liver tissue.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

In vivo liver, In vitro liver, RNA-seq, CellNet, Non-DEGs, Non-DEGsDTU−, Pathway coverage

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690GUPTA, Rajinder, Yannick SCHROODERS, Duncan HAUSER, Marcel VAN HERWIJNEN, Wiebke ALBRECHT, Bas TER BRAAK, Tim BRECKLINGHAUS, Jose V. CASTELL, Marcel LEIST, Florian CAIMENT, 2021. Comparing in vitro human liver models to in vivo human liver using RNA-Seq. In: Archives of Toxicology. Springer. 2021, 95(2), pp. 573-589. ISSN 0340-5761. eISSN 1432-0738. Available under: doi: 10.1007/s00204-020-02937-6
BibTex
@article{Gupta2021-02Compa-51827,
  year={2021},
  doi={10.1007/s00204-020-02937-6},
  title={Comparing in vitro human liver models to in vivo human liver using RNA-Seq},
  number={2},
  volume={95},
  issn={0340-5761},
  journal={Archives of Toxicology},
  pages={573--589},
  author={Gupta, Rajinder and Schrooders, Yannick and Hauser, Duncan and van Herwijnen, Marcel and Albrecht, Wiebke and Ter Braak, Bas and Brecklinghaus, Tim and Castell, Jose V. and Leist, Marcel and Caiment, Florian}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/51827">
    <dc:contributor>Leist, Marcel</dc:contributor>
    <dc:language>eng</dc:language>
    <dc:creator>Hauser, Duncan</dc:creator>
    <dc:contributor>Ter Braak, Bas</dc:contributor>
    <dc:creator>Caiment, Florian</dc:creator>
    <dc:creator>Schrooders, Yannick</dc:creator>
    <dc:contributor>Gupta, Rajinder</dc:contributor>
    <dc:contributor>Brecklinghaus, Tim</dc:contributor>
    <dc:contributor>Schrooders, Yannick</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>van Herwijnen, Marcel</dc:creator>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-17T13:10:12Z</dc:date>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dc:contributor>Caiment, Florian</dc:contributor>
    <dcterms:abstract xml:lang="eng">The liver plays an important role in xenobiotic metabolism and represents a primary target for toxic substances. Many different in vitro cell models have been developed in the past decades. In this study, we used RNA-sequencing (RNA-Seq) to analyze the following human in vitro liver cell models in comparison to human liver tissue: cancer-derived cell lines (HepG2, HepaRG 3D), induced pluripotent stem cell-derived hepatocyte-like cells (iPSC-HLCs), cancerous human liver-derived assays (hPCLiS, human precision cut liver slices), non-cancerous human liver-derived assays (PHH, primary human hepatocytes) and 3D liver microtissues. First, using CellNet, we analyzed whether these liver in vitro cell models were indeed classified as liver, based on their baseline expression profile and gene regulatory networks (GRN). More comprehensive analyses using non-differentially expressed genes (non-DEGs) and differential transcript usage (DTU) were applied to assess the coverage for important liver pathways. Through different analyses, we noticed that 3D liver microtissues exhibited a high similarity with in vivo liver, in terms of CellNet (C/T score: 0.98), non-DEGs (10,363) and pathway coverage (highest for 19 out of 20 liver specific pathways shown) at the beginning of the incubation period (0 h) followed by a decrease during long-term incubation for 168 and 336 h. PHH also showed a high degree of similarity with human liver tissue and allowed stable conditions for a short-term cultivation period of 24 h. Using the same metrics, HepG2 cells illustrated the lowest similarity (C/T: 0.51, non-DEGs: 5623, and pathways coverage: least for 7 out of 20) with human liver tissue. The HepG2 are widely used in hepatotoxicity studies, however, due to their lower similarity, they should be used with caution. HepaRG models, iPSC-HLCs, and hPCLiS ranged clearly behind microtissues and PHH but showed higher similarity to human liver tissue than HepG2 cells. In conclusion, this study offers a resource of RNA-Seq data of several biological replicates of human liver cell models in vitro compared to human liver tissue.</dcterms:abstract>
    <dc:contributor>Hauser, Duncan</dc:contributor>
    <dcterms:title>Comparing in vitro human liver models to in vivo human liver using RNA-Seq</dcterms:title>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/51827/1/Gupta_2-1efbx95aptpk2.pdf"/>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-17T13:10:12Z</dcterms:available>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:creator>Albrecht, Wiebke</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/51827/1/Gupta_2-1efbx95aptpk2.pdf"/>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:contributor>Albrecht, Wiebke</dc:contributor>
    <dc:creator>Ter Braak, Bas</dc:creator>
    <dc:creator>Castell, Jose V.</dc:creator>
    <dc:creator>Brecklinghaus, Tim</dc:creator>
    <dc:creator>Gupta, Rajinder</dc:creator>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/51827"/>
    <dcterms:issued>2021-02</dcterms:issued>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>van Herwijnen, Marcel</dc:contributor>
    <dc:contributor>Castell, Jose V.</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Leist, Marcel</dc:creator>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Ja
Diese Publikation teilen